What is the official ID of this bill?
The official print number for this legislation is HR 1082.
Enhanced Safety and Transparency for Human Cell and Tissue Transplants.
This Act mandates a national education campaign to inform the public and healthcare providers about the risks and benefits of human cell and tissue transplants. It significantly increases civil penalties for companies that violate safety regulations concerning these products, aiming to enhance public health protection. The law also requires greater transparency in the FDA's oversight of tissue establishments.
Key points
Mandatory national education campaign for the public and medical staff on safe tissue donation and transplant procedures.
Introduction of severe financial penalties (up to $10 million) for entities violating safety rules for cell and tissue products.
Increased FDA oversight transparency: required publication of data on tissue establishment inspections and regulatory response times.
Status:
Passed House
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.